Cover Image
Market Research Report

Efficacy Testing Market by Service Type (Antimicrobial/Preservative Efficacy Testing, Disinfectant Efficacy Testing (Surface, Suspension)), Application (Pharmaceutical Manufacturing, Cosmetic & Personal Care Products, Consumer) - Global Forecast to 2025

Published by MarketsandMarkets Product code 963421
Published Content info 138 Pages
Delivery time: 1-2 business days
Price
Back to Top
Efficacy Testing Market by Service Type (Antimicrobial/Preservative Efficacy Testing, Disinfectant Efficacy Testing (Surface, Suspension)), Application (Pharmaceutical Manufacturing, Cosmetic & Personal Care Products, Consumer) - Global Forecast to 2025
Published: October 6, 2020 Content info: 138 Pages
Description

The global efficacy testing market is projected to reach USD 333 million by 2025 from USD 261 million in 2020, at a CAGR of 5.0% during the forecast period. The growth of this market is mainly driven by the increasing use of surface disinfectants and preservatives in pharma, biopharma, and cosmetics industries for contamination control and product stability; growing preference for outsourcing efficacy testing; and the rising adoption of the QbD approach

"By method type, the traditional test method for the largest share of the antimicrobial/preservative testing market"

In the traditional test method, a sample of the pharmaceutical or cosmetic product is inoculated with a microbial suspension of a population of a regulatory recognized key microorganism. This is followed by sampling and the determination of the number of colony-forming units (CFU) and the microbial survival rate with the help of aerobic plate count, surface spread, or membrane filtration techniques after a suitable incubation time. As these test methods are in accordance with the guidelines and standards set by regulatory authorities, they are widely used by service providers

"Asia Pacific: The fastest-growing region in the efficacy testing market."

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the fast-growing pharmaceutical industry in this region, favorable government policies, and the increasing number of pharmaceutical companies establishing manufacturing facilities in APAC countries.

"North America: the largest share of the efficacy testing market"

North America accounted for the largest share of the efficacy testing market. Factors such as the presence of a wellestablished pharmaceutical industry in the region, the high R&D expenditure, a strong presence of major service providers, and rising outsourcing of analytical testing (including efficacy testing) by pharmaceutical and cosmetic companies in the region are the major factors driving the market growth.

Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs.

The break-up of the primaries is as follows:

  • By Respondent- Supply Side- 80%, Demand Side-20%
  • By Designation- Executives- 25%, CXOs- 20%, Managers - 55%
  • By Region- North America - 50%, Europe - 20%, APAC - 20%, RoW- 10%

The efficacy testing market is dominated by a few globally established players such as Charles River Laboratories (US), WuXi AppTec (China), Eurofins Scientific (Luxembourg), SGS (Switzerland), Intertek Group (UK), Nelson Laboratories, LLC (a Sotera Health company, US), Microbac Laboratories, Inc. (US), Almac Group (UK), North American Science Associates, Inc. (US), Toxikon (US), Pacific Biolabs (US), MSL Solution Providers (UK), Intertek Group PLC (UK), Accugen Laboratories, Inc. (US), Consumer Product Testing Company (US), Lucideon (UK), BioScience Laboratories, Inc. (US), ALS Limited (Australia), Microchem Laboratory (US), Oxford Biosciences Ltd. (UK), Abbott Analytical (Australia), Helvic Laboratories (a Tentamus Company, UK), Honeyman Group Limited (UK), Danish Technological Institute (DTI, Denmark), and BluTest Laboratories Limited (UK).

Research Coverage:

The report segments the efficacy testing market based on region (Asia Pacific, Europe, North America, and RoW), service type (disinfectant efficacy testing and antimicrobial/preservative efficacy testing), application (pharmaceutical manufacturing applications, cosmetics and personal care product applications, consumer product applications, and medical device applications).

The report also provides a comprehensive review of market drivers, challenges, and opportunities in the efficacy testing market

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the efficacy testing market and provides them information on key market drivers, challenges, and opportunities.

Table of Contents
Product Code: BT 5932

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Breakdown of primary sources
    • FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 2 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS
    • FIGURE 3 EFFICACY TESTING MARKET: FINAL CAGR PROJECTIONS (2020-2025)
    • FIGURE 4 EFFICACY TESTING MARKET: CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS, CHALLENGES, AND OPPORTUNITIES
    • FIGURE 5 EFFICACY TESTING MARKET: SEGMENTAL ASSESSMENT
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 6 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET RANKING ANALYSIS
  • 2.5 RESEARCH ASSUMPTIONS

3 EXECUTIVE SUMMARY

    • FIGURE 7 EFFICACY TESTING MARKET, BY SERVICE TYPE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 8 EFFICACY TESTING MARKET, BY APPLICATION, 2020-2025
    • FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE EFFICACY TESTING MARKET

4 PREMIUM INSIGHTS

  • 4.1 EFFICACY TESTING MARKET OVERVIEW
    • FIGURE 10 GROWING PREFERENCE FOR OUTSOURCING EFFICACY TESTING TO DRIVE MARKET GROWTH
  • 4.2 ASIA PACIFIC: EFFICACY TESTING MARKET, BY APPLICATION & COUNTRY (2019)
    • FIGURE 11 PHARMACEUTICAL MANUFACTURING APPLICATIONS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2019
  • 4.3 DISINFECTANT EFFICACY TESTING MARKET, BY METHOD
    • FIGURE 12 SURFACE TEST METHOD SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 13 EFFICACY TESTING MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing use of surface disinfectants and preservatives in pharma, biopharma, and cosmetics industries for contamination control and product stability
        • 5.2.1.1.1 Rising focus on contamination control
        • 5.2.1.1.2 Increasing concerns over product stability
      • 5.2.1.2 Growing preference for outsourcing efficacy testing
      • 5.2.1.3 Rising adoption of the Quality by Design approach
    • 5.2.2 OPPORTUNITIES
      • 5.2.2.1 Emerging countries in the Asia Pacific region
    • 5.2.3 CHALLENGES
      • 5.2.3.1 Time-consuming process
  • 5.3 REGULATORY ANALYSIS
    • 5.3.1 DISINFECTANT EFFICACY TESTING
    • 5.3.2 ANTIMICROBIAL EFFICACY TESTING
  • 5.4 IMPACT OF COVID-19 ON EFFICACY TESTING SERVICES

6 EFFICACY TESTING MARKET, BY SERVICE TYPE

  • 6.1 INTRODUCTION
    • TABLE 1 EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018-2025 (USD MILLION)
  • 6.2 DISINFECTANT EFFICACY TESTING
    • 6.2.1 RISING USE OF SURFACE DISINFECTANTS IN MANUFACTURING FACILITIES FOR CONTAMINATION CONTROL TO BOOST MARKET GROWTH
    • TABLE 2 DISINFECTANT EFFICACY TESTING MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 3 NORTH AMERICA: DISINFECTANT EFFICACY TESTING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 4 EUROPE: DISINFECTANT EFFICACY TESTING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 5 APAC: DISINFECTANT EFFICACY TESTING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 6 ROW: DISINFECTANT EFFICACY TESTING MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 7 DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
    • 6.2.2 SURFACE TEST METHOD
    • TABLE 8 SURFACE TEST METHOD MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 9 NORTH AMERICA: SURFACE TEST METHOD MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 10 EUROPE: SURFACE TEST METHOD MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 11 APAC: SURFACE TEST METHOD MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 6.2.3 SUSPENSION TEST METHOD
    • TABLE 12 SUSPENSION TEST METHOD MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 13 NORTH AMERICA: SUSPENSION TEST METHOD MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 14 EUROPE: SUSPENSION TEST METHOD MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 15 APAC: SUSPENSION TEST METHOD MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 6.3 ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING
    • 6.3.1 AET/PET TESTING ENSURES PRODUCTS HAVE MET THE REQUIRED QUALITY, SAFETY, AND PERFORMANCE STANDARDS
    • TABLE 16 EUROFINS SCIENTIFIC AET TEST PROTOCOL
    • TABLE 17 ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 18 NORTH AMERICA: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 19 EUROPE: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 20 APAC: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 21 ROW: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 22 ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
    • 6.3.2 TRADITIONAL TEST METHOD
    • TABLE 23 TRADITIONAL TEST METHOD MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 6.3.3 RAPID TEST METHOD
    • TABLE 24 RAPID TEST METHOD MARKET, BY REGION, 2018-2025 (USD MILLION)

7 EFFICACY TESTING MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 25 EFFICACY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • 7.2 PHARMACEUTICAL MANUFACTURING APPLICATIONS
    • 7.2.1 INCREASING FOCUS ON ENSURING THE QUALITY OF DRUGS TO DRIVE MARKET GROWTH
    • TABLE 26 EFFICACY TESTING MARKET FOR PHARMACEUTICAL MANUFACTURING APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 27 NORTH AMERICA: EFFICACY TESTING MARKET FOR PHARMACEUTICAL MANUFACTURING APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 28 EUROPE: EFFICACY TESTING MARKET FOR PHARMACEUTICAL MANUFACTURING APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 29 APAC: EFFICACY TESTING MARKET FOR PHARMACEUTICAL MANUFACTURING APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • 7.3 COSMETICS AND PERSONAL CARE PRODUCT APPLICATIONS
    • 7.3.1 EFFICACY TESTING IS AN ESSENTIAL PART OF THE STABILITY TESTING REGIMEN OF COSMETICS
    • TABLE 30 EFFICACY TESTING MARKET FOR COSMETICS AND PERSONAL CARE PRODUCT APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 31 NORTH AMERICA: EFFICACY TESTING MARKET FOR COSMETICS AND PERSONAL CARE PRODUCT APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 32 EUROPE: EFFICACY TESTING MARKET FOR COSMETICS AND PERSONAL CARE PRODUCT APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 33 APAC: EFFICACY TESTING MARKET FOR COSMETICS AND PERSONAL CARE PRODUCT APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • 7.4 CONSUMER PRODUCT APPLICATIONS
    • 7.4.1 GROWING FOCUS ON A HEALTHY ENVIRONMENT IN HOMES AND INDUSTRIAL FACILITIES TO DRIVE MARKET GROWTH
    • TABLE 34 EFFICACY TESTING MARKET FOR CONSUMER PRODUCT APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 35 NORTH AMERICA: EFFICACY TESTING MARKET FOR CONSUMER PRODUCT APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 36 EUROPE: EFFICACY TESTING MARKET FOR CONSUMER PRODUCT APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 37 APAC: EFFICACY TESTING MARKET FOR CONSUMER PRODUCT APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • 7.5 MEDICAL DEVICE APPLICATIONS
    • 7.5.1 IMPOSITION OF RIGOROUS GOVERNMENT REGULATIONS IS A MAJOR FACTOR DRIVING MARKET GROWTH
    • TABLE 38 EFFICACY TESTING MARKET FOR MEDICAL DEVICE APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 39 NORTH AMERICA: EFFICACY TESTING MARKET FOR MEDICAL DEVICE APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 40 EUROPE: EFFICACY TESTING MARKET FOR MEDICAL DEVICE APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 41 APAC: EFFICACY TESTING MARKET FOR MEDICAL DEVICE APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)

8 EFFICACY TESTING MARKET, BY REGION

  • 8.1 INTRODUCTION
    • TABLE 42 EFFICACY TESTING MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 8.2 NORTH AMERICA
    • FIGURE 14 NORTH AMERICA: EFFICACY TESTING MARKET SNAPSHOT
    • TABLE 43 NORTH AMERICA: EFFICACY TESTING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 44 NORTH AMERICA: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 45 NORTH AMERICA: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
    • TABLE 46 NORTH AMERICA: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
    • TABLE 47 NORTH AMERICA: EFFICACY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 8.2.1 US
      • 8.2.1.1 The US dominated the North American efficacy testing market in 2019
    • TABLE 48 US: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 49 US: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
    • TABLE 50 US: EFFICACY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 8.2.2 CANADA
      • 8.2.2.1 Government initiatives to drive market growth in Canada
    • TABLE 51 CANADA: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 52 CANADA: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
    • TABLE 53 CANADA: EFFICACY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • 8.3 EUROPE
    • TABLE 54 EUROPE: EFFICACY TESTING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 55 EUROPE: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 56 EUROPE: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
    • TABLE 57 EUROPE: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
    • TABLE 58 EUROPE: EFFICACY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 8.3.1 GERMANY
      • 8.3.1.1 Germany is the largest market for efficacy testing services in Europe
    • TABLE 59 GERMANY: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 60 GERMANY: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
    • TABLE 61 GERMANY: EFFICACY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 8.3.2 FRANCE
      • 8.3.2.1 High demand for cosmetic products in France will drive growth in the efficacy testing market for cosmetic product applications
    • TABLE 62 FRANCE: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 63 FRANCE: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
    • TABLE 64 FRANCE: EFFICACY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 8.3.3 UK
      • 8.3.3.1 Efficacy testing market in the UK is primarily driven by the enforcement of regulatory and industry standards
    • TABLE 65 UK: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 66 UK: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
    • TABLE 67 UK: EFFICACY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 8.3.4 ITALY
      • 8.3.4.1 Increasing pharmaceutical production in Italy will drive the demand for efficacy testing for pharmaceutical applications
    • TABLE 68 ITALY: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 69 ITALY: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
    • TABLE 70 ITALY: EFFICACY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 8.3.5 SPAIN
      • 8.3.5.1 Rising R&D expenditure to boost the growth of the Spanish market
    • TABLE 71 SPAIN: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 72 SPAIN: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
    • TABLE 73 SPAIN: EFFICACY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 8.3.6 REST OF EUROPE
    • TABLE 74 ROE: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 75 ROE: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
    • TABLE 76 ROE: EFFICACY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • 8.4 APAC
    • FIGURE 15 APAC: EFFICACY TESTING MARKET SNAPSHOT
    • TABLE 77 APAC: EFFICACY TESTING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 78 APAC: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 79 APAC: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
    • TABLE 80 APAC: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
    • TABLE 81 APAC: EFFICACY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 8.4.1 CHINA
      • 8.4.1.1 China is the largest market for efficacy testing services in the Asia Pacific
    • TABLE 82 CHINA: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 83 CHINA: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
    • TABLE 84 CHINA: EFFICACY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 8.4.2 JAPAN
      • 8.4.2.1 Rising R&D investments to drive market growth in Japan
    • TABLE 85 JAPAN: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 86 JAPAN: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
    • TABLE 87 JAPAN: EFFICACY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 8.4.3 INDIA
      • 8.4.3.1 Growing pharmaceutical industry in India to drive market growth
    • TABLE 88 INDIA: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 89 INDIA: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
    • TABLE 90 INDIA: EFFICACY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 8.4.4 REST OF APAC
    • TABLE 91 ROAPAC: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 92 ROAPAC: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
    • TABLE 93 ROAPAC: EFFICACY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • 8.5 REST OF THE WORLD
    • TABLE 94 ROW: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 95 ROW: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
    • TABLE 96 ROW: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
    • TABLE 97 ROW: EFFICACY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 98 ROW: EFFICACY TESTING MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 8.5.1 LATIN AMERICA
    • TABLE 99 LATAM: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 100 LATAM: EFFICACY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 8.5.2 MIDDLE EAST AND AFRICA
    • TABLE 101 MEA: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 102 MEA: EFFICACY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)

9 COMPETITIVE LANDSCAPE

  • 9.1 COMPANY EVALUATION MATRIX
    • 9.1.1 STARS
    • 9.1.2 EMERGING LEADERS
    • 9.1.3 PERVASIVE
    • 9.1.4 EMERGING COMPANIES
    • FIGURE 16 EFFICACY TESTING MARKET: COMPANY EVALUATION MATRIX (2019)
  • 9.2 MARKET RANKING ANALYSIS
    • FIGURE 17 MARKET RANKING IN THE EFFICACY TESTING MARKET (2019)
  • 9.3 EFFICACY TESTING MARKET: GEOGRAPHIC ASSESSMENT
    • FIGURE 18 GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE EFFICACY TESTING MARKET (2019)

10 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View)**

  • 10.1 EFFICACY TESTING SERVICE PROVIDERS
    • 10.1.1 EUROFINS SCIENTIFIC
    • FIGURE 19 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
    • 10.1.2 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
    • FIGURE 20 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2019)
    • 10.1.3 WUXI APPTEC
    • FIGURE 21 WUXI APPTEC: COMPANY SNAPSHOT (2019)
    • 10.1.4 SGS SA
    • FIGURE 22 SGS SA: COMPANY SNAPSHOT (2019)
    • 10.1.5 INTERTEK GROUP PLC
    • FIGURE 23 INTERTEK GROUP: COMPANY SNAPSHOT (2019)
    • 10.1.6 MICROCHEM LABORATORY
    • 10.1.7 ACCUGEN LABORATORIES, INC.
    • 10.1.8 PACIFIC BIOLABS
    • 10.1.9 NORTH AMERICAN SCIENCE ASSOCIATES
    • 10.1.10 TOXIKON
    • 10.1.11 BIOSCIENCE LABORATORIES, INC.
    • 10.1.12 CONSUMER PRODUCT TESTING COMPANY (CPTC)
    • 10.1.13 ALMAC GROUP
    • 10.1.14 MSL SOLUTION PROVIDERS
    • 10.1.15 NELSON LABORATORIES, LLC (A SOTERA HEALTH COMPANY)
    • 10.1.16 ALS LIMITED
    • 10.1.17 ABBOTT ANALYTICAL
    • 10.1.18 BLUTEST LABORATORIES LIMITED
    • 10.1.19 LUCIDEON
    • 10.1.20 HELVIC LABORATORIES (A TENTAMUS COMPANY)
  • 10.2 MANUFACTURERS OF DISINFECTANTS
    • 10.2.1 PROCTER & GAMBLE
    • FIGURE 24 PROCTER & GAMBLE: COMPANY SNAPSHOT (2019)
    • 10.2.2 THE CLOROX COMPANY
    • FIGURE 25 THE CLOROX COMPANY: COMPANY SNAPSHOT (2019)
    • 10.2.3 3M GROUP
    • FIGURE 26 3M GROUP: COMPANY SNAPSHOT (2019)
    • 10.2.4 RECKITT BENCKISER GROUP PLC
    • FIGURE 27 RECKITT BENCKISER GROUP PLC: COMPANY SNAPSHOT (2019)
    • 10.2.5 STERIS PLC
    • FIGURE 28 STERIS PLC: COMPANY SNAPSHOT (2019)
    • 10.2.6 ECOLAB INC.
    • FIGURE 29 ECOLAB INC.: COMPANY SNAPSHOT (2019)
    • 10.2.7 CANTEL MEDICAL CORPORATION
    • FIGURE 30 CANTEL MEDICAL CORPORATION: COMPANY SNAPSHOT (2019)
    • 10.2.8 DIVERSEY, INC.
    • 10.2.9 MEDLINE INDUSTRIES, INC.
    • 10.2.10 BETCO

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

11 APPENDIX

  • 11.1 DISCUSSION GUIDE
  • 11.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.3 AVAILABLE CUSTOMIZATIONS
  • 11.4 RELATED REPORTS
  • 11.5 AUTHOR DETAILS
Back to Top